Sotera Health Q2 net revenue $255M (-4% YoY), net income $24M; cuts full-year outlook

Sotera Health Co

2023-Q2 EPS reported $0.09 revenue$475,872,000

Q2 net revenues $255M, down 4% YoY; net income $24M ($0.08 diluted EPS) vs $30M ($0.11) in Q2 2022.
Adjusted EBITDA $128M, down 6% YoY; Adjusted EPS $0.21 vs $0.27 in prior year.
Full-year 2023 guidance revised: net revenue $1.035B-$1.055B, Adjusted EBITDA $520M-$535M.
Decline driven by expected Nordion Cobalt-60 harvest schedule timing.
Total debt $2.3B, net leverage ratio 4.2x as of June 30, 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Sotera Health Co reported the quarter ended June 30, 2023 results: revenue $255 million, net income $24 million or $0.08 per diluted share, EPS $0.08 per diluted share. Guidance reaffirmed.

Period: the quarter ended June 30, 2023
Revenue: $255 million
Net income: $24 million or $0.08 per diluted share
EPS: $0.08 per diluted share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

incorporated by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Sotera Health Reports Second-Quarter and First-Half 2023 Results • Q2 2023 net revenues of $255 million decreased 4%, compared to Q2 2022, primarily driven by expected Nordion Cobalt-60 harvest schedule timing • Q2 2023 net income of $24 million or $0.08 per diluted share, compared

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Sotera Health Co filing history →

Source: SEC EDGAR

accession 0001822479-23-000049

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.